Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease. (Q53332958)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 September 2012

Language	Label	Description	Also known as
English	Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease.	scientific article published on 18 September 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

1 reference

based on heuristic

inferred from title

author name string

Guoxin Wu

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

Sethu Sankaranarayanan

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

Jacky Wong

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

Katherine Tugusheva

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

Maria S Michener

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

Xiaoping Shi

6

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

Jacquelynn J Cook

7

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

Adam J Simon

8

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

Mary J Savage

9

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

publication date

18 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

Journal of Neuroscience Research

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

90

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

12

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

2247-2258

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Acute gamma-secretase inhibition of nonhuman primate CNS shifts amyloid precursor protein (APP) metabolism from amyloid-beta production to alternative APP fragments without amyloid-beta rebound

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Increased beta-Secretase activity in cerebrospinal fluid of Alzheimer's disease subjects.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Biomarkers of Alzheimer disease in plasma

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's diseas

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Solid-phase extraction enhances detection of beta-amyloid peptides in plasma and enables Abeta quantification following passive immunization with Abeta antibodies

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Age and diagnostic performance of Alzheimer disease CSF biomarkers.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

The use of PET in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Quantitative changes in the amyloid βA4 precursor protein in Alzheimer cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Measurement of Aβ1-42 in cerebrospinal fluid is influenced by matrix effects.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer's subjects

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Pharmacological applications of a novel neoepitope antibody to a modified amyloid precursor protein-derived beta-secretase product

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23122

21 January 2018

Identifiers

10.1002/JNR.23122

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22987781

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53332958&oldid=1428319484"